India to Saudi Arabia: Mitomycin Export Trade Route
India has recorded 41 verified shipments of Mitomycin exported to Saudi Arabia, representing a combined trade value of $95.2K USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $2.3K USD. The leading Indian exporter is DHEER HEALTH CARE PRIVATE LIMITED , which accounts for 42% of total export value with 4 shipments worth $39.8K USD. On the buying side, TO THE ORDER OFF is the largest importer in Saudi Arabia with $39.8K USD in purchases. The top 3 suppliers — DHEER HEALTH CARE PRIVATE LIMITED , ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED — together control 66% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Saudi Arabia Mitomycin corridor is one of India's established pharmaceutical export routes, with 41 shipments documented worth a combined $95.2K USD. The route is dominated by DHEER HEALTH CARE PRIVATE LIMITED , which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's mitomycin manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $2.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 18.3%, placing it at rank #14 among India's top mitomycin export destinations globally.
On the import side, key buyers of Indian mitomycin in Saudi Arabia include TO THE ORDER OFF , TO THE CONSIGNEE-, TO THE CONSIGNEE and 21 others. TO THE ORDER OFF is the single largest importer with 4 shipments valued at $39.8K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#14
- Annual growth+18.3%
- Demand growth+15.7%
- Regulatory ease69/100
Top 10 Indian Mitomycin Exporters to Saudi Arabia
Showing top 10 of 17 Indian suppliers exporting Mitomycin to Saudi Arabia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DHEER HEALTH CARE PRIVATE LIMITED Avg $9.9K per shipment | 4 | $39.8K | 41.8% |
| 2 | ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED Avg $3.8K per shipment | 3 | $11.3K | 11.9% |
| 3 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $1.3K per shipment | 9 | $11.3K | 11.9% |
| 4 | DHEER HEALTH CARE PRIVATE LIMITED Avg $4.5K per shipment | 1 | $4.5K | 4.7% |
| 5 | SURGI EDGE (INDIA) Avg $1.1K per shipment | 4 | $4.3K | 4.5% |
| 6 | ZYPHAR S PHARMACEUTICS PRIVATE LIMITED Avg $4.1K per shipment | 1 | $4.1K | 4.3% |
| 7 | SURGI EDGE (INDIA) Avg $3.8K per shipment | 1 | $3.8K | 4.0% |
| 8 | SHREEJI MICRO SYSTEMS INC Avg $1.8K per shipment | 2 | $3.6K | 3.7% |
| 9 | MALAMBI HEALTHCARE AND EXPORTS Avg $624 per shipment | 4 | $2.5K | 2.6% |
| 10 | ASPIRA BIOHEALTH LLP Avg $1.1K per shipment | 2 | $2.2K | 2.3% |
This table shows the top 10 of 17 Indian companies exporting mitomycin to Saudi Arabia, ranked by total trade value. The listed exporters are: DHEER HEALTH CARE PRIVATE LIMITED , ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, DHEER HEALTH CARE PRIVATE LIMITED, SURGI EDGE (INDIA) , ZYPHAR S PHARMACEUTICS PRIVATE LIMITED, SURGI EDGE (INDIA), SHREEJI MICRO SYSTEMS INC, MALAMBI HEALTHCARE AND EXPORTS, ASPIRA BIOHEALTH LLP . DHEER HEALTH CARE PRIVATE LIMITED is the dominant supplier with 4 shipments worth $39.8K USD, giving it a 42% market share. The top 3 suppliers together account for 66% of the total trade value on this route.
Showing top 10 of 17 total Indian exporters on the India to Saudi Arabia Mitomycin export route.
Top 10 Mitomycin Importers in Saudi Arabia
Showing top 10 of 24 known buyers in Saudi Arabia receiving Mitomycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian mitomycin in Saudi Arabia include TO THE ORDER OFF , TO THE CONSIGNEE-, TO THE CONSIGNEE, Al-Badr Foundation for the trade, TO THE ORDER, among 24 total buyers. The largest importer is TO THE ORDER OFF , accounting for $39.8K USD across 4 shipments — representing 42% of all mitomycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER OFF | 4 | $39.8K | 41.8% |
| 2 | TO THE CONSIGNEE- | 3 | $11.3K | 11.9% |
| 3 | TO THE CONSIGNEE | 2 | $6.2K | 6.5% |
| 4 | Al-Badr Foundation for the trade | 1 | $6.0K | 6.3% |
| 5 | TO THE ORDER | 1 | $4.5K | 4.7% |
| 6 | TO THE ORDER OF . | 4 | $4.3K | 4.5% |
| 7 | TO THE ORDER OF | 1 | $3.8K | 4.0% |
| 8 | VISION MEDICAL CORPORATION FOR TRADING | 3 | $3.6K | 3.8% |
| 9 | QENTAR ELAJ MEDICAL EST | 2 | $2.2K | 2.3% |
| 10 | ABDULLAH ALJAFA | 1 | $2.0K | 2.1% |
Showing top 10 of 24 Mitomycin importers in Saudi Arabia on this route.
Top 10 Mitomycin Formulations Imported by Saudi Arabia
Showing top 10 of 33 product formulations shipped on the India to Saudi Arabia Mitomycin route, ranked by trade value
Saudi Arabia imports a wide range of mitomycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Harmless Medicine- MITOMYCIN 10MG INJECT — accounts for $30.7K USD across 1 shipments. There are 33 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Harmless Medicine- MITOMYCIN 10MG INJECT | 1 | $30.7K | 32.2% |
| 2 | AS PER INVOICE NO: ZPPL/XP/2425/029 DATE: 11.04.2024 SR NO:05 MITOMYCIN INJECTION IP 10MG | 1 | $6.7K | 7.0% |
| 3 | Mitomycin 10mg Inj | 2 | $6.1K | 6.4% |
| 4 | Harmless Medicine Mitomycin 10mg Inject | 1 | $4.5K | 4.7% |
| 5 | ASPER INVOICE NO ZPPL XP 2223 472 DATE 27 03 2023 SR NO 7 MITOMYCIN INJECTION IP 10 MG | 1 | $4.1K | 4.3% |
| 6 | HARMLESS MEDICINE, MITOMYCIN 10MH INJECT | 1 | $4.1K | 4.3% |
| 7 | MITOMYCIN INJECTION IP 10MG | 1 | $3.8K | 4.0% |
| 8 | Mitomycin 10mg Inj. | 3 | $3.6K | 3.8% |
| 9 | ASPER INVOICE NO: ZPPL/XP/2324/339 DATE:08/12/2023 SR NO. 6 MITOMYCIN INJECTIONIP 10MG | 1 | $3.1K | 3.2% |
| 10 | MITOMYCIN 10 MG | 3 | $2.7K | 2.8% |
Showing top 10 of 33 Mitomycin formulations imported by Saudi Arabia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 9 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's mitomycin exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. DHEER HEALTH CARE PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DHEER HEALTH CARE PRIVATE LIMITED , ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED — together account for 66% of total trade value on this route. The average shipment value of $2.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as as per invoice no: zppl/xp/2425/029 date: 11.04.2024 sr no:05 mitomycin injection ip 10mg and mitomycin 10mg inj , suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER OFF is the largest importer with 4 shipments worth $39.8K USD — representing 42% of all mitomycin imports from India on this route. A total of 24 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $95.2K
- Avg. Shipment
- $2.3K
- Suppliers
- 17
- Buyers
- 24
- Transit (Sea)
- ~21 days
- Annual Growth
- +18.3%
Other Mitomycin Routes
Unlock the Full India to Saudi Arabia Mitomycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 41 shipments on this route.
Frequently Asked Questions — India to Saudi Arabia Mitomycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Mitomycin to Saudi Arabia?
The leading Indian exporters of Mitomycin to Saudi Arabia are DHEER HEALTH CARE PRIVATE LIMITED , ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED. DHEER HEALTH CARE PRIVATE LIMITED holds the largest market share at approximately 42% of total trade value on this route.
Q What is the total value of Mitomycin exports from India to Saudi Arabia?
India exports Mitomycin to Saudi Arabia worth approximately $95.2K USD across 41 recorded shipments. The average value per shipment is $2.3K USD.
Q Which ports does India use to ship Mitomycin to Saudi Arabia?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 9 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Saudi Arabia for Mitomycin?
The average transit time for Mitomycin shipments from India to Saudi Arabia is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Saudi Arabia Mitomycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.3% with demand growth tracking at 15.7%. The route is ranked #14 among India's top Mitomycin export destinations globally.
Q How many suppliers are active on the India to Saudi Arabia Mitomycin route?
There are currently 17 active Indian suppliers exporting Mitomycin to Saudi Arabia. The market is moderately concentrated with DHEER HEALTH CARE PRIVATE LIMITED accounting for 42% of total shipment value.
Q Who are the main importers of Mitomycin from India in Saudi Arabia?
The leading importers of Indian Mitomycin in Saudi Arabia include TO THE ORDER OFF , TO THE CONSIGNEE-, TO THE CONSIGNEE, Al-Badr Foundation for the trade, TO THE ORDER. TO THE ORDER OFF is the largest buyer with 4 shipments worth $39.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Saudi Arabia export trade corridor identified from Indian Customs (DGFT) records for Mitomycin.
- 2.Supplier/Buyer Matching: 17 Indian exporters and 24 importers in Saudi Arabia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 41 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
41 Verified Shipments
17 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists